Healthcare Research Network’s elite Clinical Research Site Network includes a state of the art Hematology/Oncology clinical research site in Chicago-land.
Healthcare Research Network owns and operates a large 3 location clinical research site covering Chicago-land and NW Indiana. Our Oncology focus is in Phase II, Phase III and Phase IV protocols. Our Principal Investigators are experienced clinicians and researchers who own/operate a comprehensive cancer care center from which we recruit patients. We incorporate all aspects of comprehensive clinical care and research including an integrated infusion center, pharmacy and radiology facility. We utilize Central IRB’s to ensure efficiency and incorporate 1 streamlined point of contact for all CDA’s, feasibility questionnaires, contracts and budgets. Most centers take months to complete the start-up process. We can complete contracting and start-up and begin enrolling patients in 4 weeks! In fact, we are routinely asked by sponsors and CRO’s to be a study’s 1st enrolling site.
Our therapeutic focus includes the following:
Breast Cancer
Endometrial Cancer
Lung Cancer
Melanoma
Prostate Cancer
Colon and Rectal Cancer
Bladder Cancer
Kidney Cancer
Myelodysplastic Syndrome (MDS)
Lymphomas
Leukemia
Thyroid Cancer
Healthcare Research Network’s elite Clinical Research Site Network includes a state of the art Hematology/Oncology clinical research site in Chicago-land.
Healthcare Research Network owns and operates a large 3 location clinical research site covering Chicago-land and NW Indiana. Our Oncology focus is in Phase II, Phase III and Phase IV protocols. Our Principal Investigators are experienced clinicians and researchers who own/operate a comprehensive cancer care center from which we recruit patients. We incorporate all aspects of comprehensive clinical care and research including an integrated infusion center, pharmacy and radiology facility. We utilize Central IRB’s to ensure efficiency and incorporate 1 streamlined point of contact for all CDA’s, feasibility questionnaires, contracts and budgets. Most centers take months to complete the start-up process. We can complete contracting and start-up and begin enrolling patients in 4 weeks! In fact, we are routinely asked by sponsors and CRO’s to be a study’s 1st enrolling site.
Our therapeutic focus includes the following:
Breast Cancer
Endometrial Cancer
Lung Cancer
Melanoma
Prostate Cancer
Colon and Rectal Cancer
Bladder Cancer
Kidney Cancer
Myelodysplastic Syndrome (MDS)
Lymphomas
Leukemia
Thyroid Cancer
Healthcare Research Network is committed to excellence in every aspect of Hematology/Oncology clinical research.
We have invested heavily to create “best in class’ SOP’s and processes governing good clinical practices and superior patient recruitment. We have broken new ground as the first to build freestanding fully integrated Hematology/Oncology clinical research facilities. These unique offerings, coupled with our integrity and experience, translate into documented superior clinical research outcomes. Together, throughout our entire network Healthcare Research Network is setting the standard for quality clinical research.
Healthcare Research Network is committed to excellence in every aspect of Hematology/Oncology clinical research.
We have invested heavily to create “best in class’ SOP’s and processes governing good clinical practices and superior patient recruitment. We have broken new ground as the first to build freestanding fully integrated Hematology/Oncology clinical research facilities. These unique offerings, coupled with our integrity and experience, translate into documented superior clinical research outcomes. Together, throughout our entire network Healthcare Research Network is setting the standard for quality clinical research.
